Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal cell and mitochondrial membranes, specifically the inner mitochondrial membrane (IMM), are essential structural components that support the high metabolic demands of photoreceptors and retinal pigment epithelium (RPE) cells (Fisher and Ferrington, 2018; PubMed: 30121464). These membranes contain cardiolipin, a unique tetra-acyl phospholipid that is vital for the structural integrity of mitochondrial cristae and the efficient functioning of the electron transport chain (ETC) (Birk et al., 2013; PubMed: 23255577). In neurodegenerative ocular diseases such as age-related macular degeneration (AMD) and Leber hereditary optic neuropathy (LHON), oxidative stress leads to the peroxidation of cardiolipin, which causes mitochondrial dysfunction, increased reactive oxygen species (ROS) production, and eventual cell death (Yu-Wai-Man et al., 2011; PubMed: 21303853). Therapeutic agents like elamipretide (MTP-131) target these membranes by binding to cardiolipin, thereby stabilizing the mitochondrial structure, improving ATP production, and reducing oxidative damage (Allen et al., 2020; PubMed: 32453154). This stabilization helps preserve retinal function and slow the progression of vision loss in conditions characterized by mitochondrial decay.
Stabilization of cardiolipin within the inner mitochondrial membrane to maintain cristae structure, optimize electron transport chain function, and reduce the production of reactive oxygen species (ROS) (Birk et al., 2013; PubMed: 23255577).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal cell and mitochondrial membrane.